Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/12/2003CN1127486C Phthalazine derivatives phosphodiesterase 4 inhibitors
11/12/2003CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
11/12/2003CN1127482C Sulfuryl diphenyl indole compound and preparation process and use in medicine
11/12/2003CN1127480C Colchicine derivative and its treatment use
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/12/2003CN1127478C Zinc p-acetlaminoacetate with anti ulcer and immunoregulation action
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/12/2003CN1127344C Oral pill for treating diabetes and its complication
11/12/2003CN1127341C Medicine for treating dysentery
11/12/2003CN1127340C Composition containing nicotine compound, use thereof and its formation method
11/12/2003CN1127339C Use of carbonic anhydrase inhibitor acetazolamide in preparing male contraceptives
11/12/2003CN1127338C Anti-vaginitis composition for topiical use comprising one or move anti-vaginitis medicaments and one or more local anaesthetics
11/12/2003CN1127337C Method of treating or preventing non-viral microbial infection
11/12/2003CN1127336C Remedy for pulmonary heart
11/12/2003CN1127335C AIDS resisting medicine and its use thereof
11/12/2003CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker
11/12/2003CN1127294C Endoparasiticidal and ectoparasiticidal agents
11/11/2003US6647358 Pharmacokinetic-based drug design tool and method
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646157 Method for making HBED
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646143 Anticancer agents; skin disorders
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646129 Cyanoguanidines as cell proliferation inhibitors
11/11/2003US6646128 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives
11/11/2003US6646120 Polysaccharides with side chains of methylcarboxylate, carboxymethylbenzylamide, sulfate and sulfonate groups; use as anti-thrombotic, substitute for plasma and modulator of cell proliferation
11/11/2003US6646108 Process for isolating IgG and IgA
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6646008 Administering peroxisome proliferator activated receptor(PPAR) and retinoid acid receptor agonists such as 6-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl) nicotinic acid, for prophylaxis of tumors
11/11/2003US6646007 Process for preparing a pharmaceutical formulation containing levothyroxine sodium
11/11/2003US6646006 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
11/11/2003US6646005 Administering nontoxic sulfur compounds such as 3,5-dibromo-4-(4-hydroxy-3-iodophenylsulfonyl)phenylacetic acid, having side effect reduction; alopecia
11/11/2003US6646004 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/11/2003US6646003 Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
11/11/2003US6646001 Administering to a glaucoma affected eye a combination of an intraocular pressure lowering prostaglandin FP receptor agonist, and a prostaglandin synthesis inhibitor other than diclofenac or fluorometholone
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645998 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/11/2003US6645997 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma
11/11/2003US6645995 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
11/11/2003US6645994 Method of treating dry eye disorders
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645988 Pharmaceutical preparations comprising substituted benzimidazole proton pump inhibitors with fast acting buffer; gastric acid stability for enteral administration
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645986 Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
11/11/2003US6645985 Pyrazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them, and method of treating
11/11/2003US6645983 Pharmaceutical compositions comprising 4-quinolones for treating cancers
11/11/2003US6645982 Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of production
11/11/2003US6645981 Antimicrobial quinolones, their compositions and uses
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645978 Topical mixtures comprising mucin stimulants and carriers, for prophylaxis trauma from surgery or contact lenses
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645975 Process for the preparation of dinaposoline
11/11/2003US6645974 Androgen receptor modulators and methods for use thereof
11/11/2003US6645973 Heterocyclic amines such as 1-carboxymethyl-4-(4-chlorophenyl) spiro(2H-1-benzopyran-2,4'-piperidine)hydrochloride used for therapy of nervous system disorders; Alzheimer's, Parkinson's and Huntington's disease
11/11/2003US6645972 Administering nucleoside analogues such as beta-L-dioxolane cytidine as tyrosine kinase inhibitors or anticarcinogenic agents
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645967 Arylpiperazines having activity at the serotonin 1A receptor
11/11/2003US6645966 Reverse malaria drug resistance
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/11/2003US6645961 Dry granulation formulation for an HIV protease inhibitor
11/11/2003US6645960 Antifungal sordaricin derivatives
11/11/2003US6645959 Method for treating postoperative ileus
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645957 Useful in preventing and treating allergic immunological diseases; treating asthma, atopic dermatitis, allergic rhinitis, inflammatory large bowel disease, contact dermatitis
11/11/2003US6645956 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment
11/11/2003US6645955 3,6-dihydroxy-24-amidyl steroid derivatives
11/11/2003US6645954 Such as (1,2)-oxazolo(4,5-b)-17alpha-pregna-2,4-dien-20-yn-17-beta-ol; for treatment of male hypogonadism/androgen deficiency
11/11/2003US6645951 Benzopyran or thiobenzopyran derivatives
11/11/2003US6645950 Benzimidazole vascular damaging agents
11/11/2003US6645948 Nutritional composition for the treatment of connective tissue
11/11/2003US6645947 Adhesive N, O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
11/11/2003US6645946 Delivery of a therapeutic agent in a formulation for reduced toxicity
11/11/2003US6645945 Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors
11/11/2003US6645943 Method of down-regulating gene expression
11/11/2003US6645940 Oligosaccharide derivatives and process for producing the same
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645935 Synthesis of glycoconjugates of the lewis Y epitope and uses thereof
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/11/2003US6645774 Administering for treatment of obesity, bulimia or anorexia
11/11/2003US6645751 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/11/2003US6645535 Method of making coated chewing gum products containing various antacids
11/11/2003US6645529 Soluble coatings; variations in bulk density
11/11/2003US6645527 Stabilized sustained release tramadol formulations
11/11/2003US6645526 Storage-stable dosage form of a thyroxine active drug formulation for the treatment of thyroid, containing levothyroxine sodium as active drug substance, an alditol and a sacchride; increased shelf-life
11/11/2003US6645523 Paroxetine compositions and processes for making the same
11/11/2003US6645521 Local prevention or amelioration of pain from surgically closed wounds
11/11/2003US6645520 Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
11/11/2003US6645513 Treatment of skin with adenosine or adenosine analog
11/11/2003US6645510 Method of treating topical ailments
11/11/2003US6645508 Stabilized with N-methyl-2-pyrrolidone; topical composition stable for up to 2 months
11/11/2003US6645506 Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
1 ... 5281 5282 5283 5284 5285 5286 5287 5288 5289 5290 5291 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 ... 7860